Doctors' Understanding of Survival Statistics
MPIB
Study of Primary Care Physicians' Understanding and Use of Different Survival Measures
1 other identifier
observational
778
1 country
1
Brief Summary
The probably most commonly used measure for expressing the pay-offs of early detection and treatment are survival rates. Yet, over time and groups this metric comes with several biases and thus, is not reliable for judging such benefits. Epidemiologists recommend using reduction of disease-specific mortality rates instead, which is unbiased. The purpose of the study is to investigate how primary care physicians understand and use different survival measures for determining the benefit of cancer screening tests.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 18, 2009
CompletedFirst Posted
Study publicly available on registry
September 22, 2009
CompletedStudy Start
First participant enrolled
December 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2009
CompletedResults Posted
Study results publicly available
August 15, 2011
CompletedAugust 15, 2011
July 1, 2011
Same day
September 18, 2009
May 20, 2011
July 20, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Physicians (=Participants) Recommending the Screening
The aim of the study was to learn how different medical cancer screening statistics would influence doctors' recommendation behavior and their effectiveness judgments of screening tests. For that reason the online survey study presented physicians with four different medical statistics (e.g., 5-year survival) within four successive scenarios and asked after each scenario whether they would recommend the screening to a (hypothetical) patient given the data. Options to answer are: Definitely yes, Probably yes, Probably no, Definitely no, Can't decide.
25 minutes (mean duration of the survey)
Secondary Outcomes (1)
Number of Physicians (= Participants) Assuming a Benefit of Screening
25 minutes (mean duration of the survey)
Study Arms (1)
mortality*incidence*5-year survival*early stage
Physicians will be faced in scenarios about screening with information on mortality and 5-year survival, followed by information on mortality\*incidence and 5-year survival\*early stage in a random order.
Eligibility Criteria
301 primary care physicians (internal, general, and family medicine physicians)
You may qualify if:
- primary care physicians (internal, general, and family medicine physicians)
You may not qualify if:
- all other types of physicians
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Max Planck Institute for Human Development
Berlin, 14195, Germany
Related Publications (1)
Wegwarth O, Schwartz LM, Woloshin S, Gaissmaier W, Gigerenzer G. Do physicians understand cancer screening statistics? A national survey of primary care physicians in the United States. Ann Intern Med. 2012 Mar 6;156(5):340-9. doi: 10.7326/0003-4819-156-5-201203060-00005.
PMID: 22393129DERIVED
Related Links
Limitations and Caveats
Mistaken exclusion of "exclusively outpatient" physicians due to a programming mistake of the online survey screener
Results Point of Contact
- Title
- Dr. Odette Wegwarth
- Organization
- Max Planck Institute for Human Development, Harding Center for Risk Literacy
Study Officials
- PRINCIPAL INVESTIGATOR
Odette Wegwarth, Dr.
Max Planck Institute for Human Development
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 18, 2009
First Posted
September 22, 2009
Study Start
December 1, 2009
Primary Completion
December 1, 2009
Study Completion
December 1, 2009
Last Updated
August 15, 2011
Results First Posted
August 15, 2011
Record last verified: 2011-07